Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2016

01-08-2016 | Research Article

Factors influencing subjects’ comprehension of a set of medicine package inserts

Authors: Carla Pires, Marina Vigário, Afonso Cavaco

Published in: International Journal of Clinical Pharmacy | Issue 4/2016

Login to get access

Abstract

Background Package inserts (PIs) should promote the safe and effective use of medicines. The comprehension of PIs is related to socio-demographic features, such as education. Objectives To evaluate the participants’ comprehension of a sample of PIs and to build an explanatory model of subjects’ understanding of the content of these documents. Setting The data were collected from municipalities, city halls, firefighters, the military, schools and charities from two Portuguese regions. Methods Cross-sectional descriptive survey: 503 participants, homogeneously distributed by education and gender. The self-administered tool comprised questions on socio-demographic data, literacy tasks and comprehension evaluation of 12 purposively selected PIs. A logistic regression analysis was used. Main outcome measures Scores of numeracy tasks and comprehension. Results The average comprehension score for the PIs was 63 % (±32 %), with 48 % (n = 239) of the participants scoring <75 %. The most important predictors in explaining a comprehension score ≥75 % were having >12 years of education and correctly performing a numeracy task [respectively, OR 49.6 (CI 95 %: 22.8–108) and OR 2.48 (CI 95 %: 1.5–4.2)]. Conclusion An explanatory model of subjects’ knowledge about the content of the tested PIs was built. Given that a high level of education and literacy were found to be the most relevant predictors for acceptable comprehension rates, PIs should be clearly written to assure that they are understood by all potential users, including the less educated. The evaluated PIs may thus need to be simplified.
Appendix
Available only for authorised users
Literature
1.
go back to reference Herber OR, Gies V, Schwappach D, Thürmann P, Wilm S. Patient information leaflets: informing or frightening? A focus group study exploring patients’ emotional reactions and subsequent behavior towards package leaflets of commonly prescribed medications in family practices. BMC Fam Pract. 2014;15:163.CrossRefPubMedPubMedCentral Herber OR, Gies V, Schwappach D, Thürmann P, Wilm S. Patient information leaflets: informing or frightening? A focus group study exploring patients’ emotional reactions and subsequent behavior towards package leaflets of commonly prescribed medications in family practices. BMC Fam Pract. 2014;15:163.CrossRefPubMedPubMedCentral
2.
go back to reference Hamrosi KK, Raynor DK, Aslani P. Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page? Res Soc Adm Pharm. 2014;10(4):656–68.CrossRef Hamrosi KK, Raynor DK, Aslani P. Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page? Res Soc Adm Pharm. 2014;10(4):656–68.CrossRef
3.
go back to reference Nicolson D, Knapp P, Raynor DK, Spoor P. Written information about individual medicines for consumers. Cochrane Database Syst Rev. 2009;15(2):CD002104. Nicolson D, Knapp P, Raynor DK, Spoor P. Written information about individual medicines for consumers. Cochrane Database Syst Rev. 2009;15(2):CD002104.
4.
go back to reference Vinker S, Eliyahu V, Yaphe J. The effect of drug information inserts on patient behaviour. Isr Med Assoc J. 2007;9:383–6.PubMed Vinker S, Eliyahu V, Yaphe J. The effect of drug information inserts on patient behaviour. Isr Med Assoc J. 2007;9:383–6.PubMed
5.
go back to reference Krska J, Morecroft CW. Patients’ use of information about medicine side effects in relation to experiences of suspected adverse drug reactions: a cross-sectional survey in medical in-patients. Drug Saf. 2013;36(8):673–80.CrossRefPubMed Krska J, Morecroft CW. Patients’ use of information about medicine side effects in relation to experiences of suspected adverse drug reactions: a cross-sectional survey in medical in-patients. Drug Saf. 2013;36(8):673–80.CrossRefPubMed
6.
go back to reference Shiffman S, Gerlach KK, Sembower MA, Rohay JM. Consumer understanding of prescription drug information: an illustration using an antidepressant medication. Ann Pharmacother. 2011;45(4):452–8.CrossRefPubMed Shiffman S, Gerlach KK, Sembower MA, Rohay JM. Consumer understanding of prescription drug information: an illustration using an antidepressant medication. Ann Pharmacother. 2011;45(4):452–8.CrossRefPubMed
7.
go back to reference Pires C, Vigário M, Cavaco A. Readability of medicinal package leaflets: a systematic review. Rev Saude Publica. 2015;49:1–13.CrossRef Pires C, Vigário M, Cavaco A. Readability of medicinal package leaflets: a systematic review. Rev Saude Publica. 2015;49:1–13.CrossRef
9.
go back to reference McCarthy DM, Davis TC, King JP, Mullen RJ, Bailey SC, Serper M, et al. Take-Wait-Stop: a patient-centered strategy for writing PRN medication instructions. J Health Commun. 2013;18(1):40–8.CrossRefPubMedPubMedCentral McCarthy DM, Davis TC, King JP, Mullen RJ, Bailey SC, Serper M, et al. Take-Wait-Stop: a patient-centered strategy for writing PRN medication instructions. J Health Commun. 2013;18(1):40–8.CrossRefPubMedPubMedCentral
10.
go back to reference Al Juffali L, Al Omran O, Al Aqeel S. Saudi young patient understanding of information about side effects: Verbal versus numerical expression. Saudi Pharm J. 2014;22(1):33–7.CrossRefPubMed Al Juffali L, Al Omran O, Al Aqeel S. Saudi young patient understanding of information about side effects: Verbal versus numerical expression. Saudi Pharm J. 2014;22(1):33–7.CrossRefPubMed
11.
go back to reference Knapp P, Raynor DK, Woolf E, Gardner PH, Carrigan N, McMillan B. Communicating the risk of side effects to patients: an evaluation of UK regulatory recommendations. Drug Saf. 2009;32(10):837–49.CrossRefPubMed Knapp P, Raynor DK, Woolf E, Gardner PH, Carrigan N, McMillan B. Communicating the risk of side effects to patients: an evaluation of UK regulatory recommendations. Drug Saf. 2009;32(10):837–49.CrossRefPubMed
12.
go back to reference Gustafsson J, Kälvemark S, Nilsson G, Nilsson JL. Patient information leaflets—patients’ comprehension of information about interactions and contraindications. Pharm World Sci. 2005;27(1):35–40.CrossRefPubMed Gustafsson J, Kälvemark S, Nilsson G, Nilsson JL. Patient information leaflets—patients’ comprehension of information about interactions and contraindications. Pharm World Sci. 2005;27(1):35–40.CrossRefPubMed
13.
go back to reference Knapp P, Wanklyn P, Raynor DK, Waxman R. Developing and testing a patient information booklet for thrombolysis used in acute stroke. Int J Pharm Pract. 2010;18(6):362–9.CrossRefPubMed Knapp P, Wanklyn P, Raynor DK, Waxman R. Developing and testing a patient information booklet for thrombolysis used in acute stroke. Int J Pharm Pract. 2010;18(6):362–9.CrossRefPubMed
14.
go back to reference Dickinson D, Raynor DK, Duman M. Patient information inserts for medicines: using consumer testing to determine the most effective design. Patient Educ Couns. 2001;43(2):147–59.CrossRefPubMed Dickinson D, Raynor DK, Duman M. Patient information inserts for medicines: using consumer testing to determine the most effective design. Patient Educ Couns. 2001;43(2):147–59.CrossRefPubMed
15.
go back to reference Miquel AV, Ortín F, Marrugat J, Pavesi M. Assessment of the comprehension of new rephrasing drug package inserts. Med Clin. 2000;115(11):410–7.CrossRef Miquel AV, Ortín F, Marrugat J, Pavesi M. Assessment of the comprehension of new rephrasing drug package inserts. Med Clin. 2000;115(11):410–7.CrossRef
16.
go back to reference Raynor DK. User testing in developing patient medication information in Europe. Res Soc Adm Pharm. 2013;9(5):640–5.CrossRef Raynor DK. User testing in developing patient medication information in Europe. Res Soc Adm Pharm. 2013;9(5):640–5.CrossRef
17.
go back to reference Fuchs J. The way forward in package insert user test from a CRO’s perspective. Ther Innov Regul Sci. 2010;44:119–29.CrossRef Fuchs J. The way forward in package insert user test from a CRO’s perspective. Ther Innov Regul Sci. 2010;44:119–29.CrossRef
18.
go back to reference Roskos SE, Wallace LS, Weiss BD. Readability of consumer medication information for intranasal corticosteroid inhalers. Am J Health System Pharm. 2008;65(1):65–8.CrossRef Roskos SE, Wallace LS, Weiss BD. Readability of consumer medication information for intranasal corticosteroid inhalers. Am J Health System Pharm. 2008;65(1):65–8.CrossRef
20.
go back to reference Shrank WH, Avorn J. Educating patients about their medications: the potential and limitations of written drug information. Health Aff. 2007;26(3):731–40.CrossRef Shrank WH, Avorn J. Educating patients about their medications: the potential and limitations of written drug information. Health Aff. 2007;26(3):731–40.CrossRef
21.
go back to reference Ana B, Rosa A, Costa AF, Ávila P. A Literacia em Portugal: Resultados de uma Pesquisa Extensiva e Monográfica. [Literacy in Portugal: results of an extensive research and monograph]. Lisboa: Fundação Calouste Gulbenkian e Conselho Nacional de Educação, 1996, 27–119. ISBN 972-31-0713-9. Ana B, Rosa A, Costa AF, Ávila P. A Literacia em Portugal: Resultados de uma Pesquisa Extensiva e Monográfica. [Literacy in Portugal: results of an extensive research and monograph]. Lisboa: Fundação Calouste Gulbenkian e Conselho Nacional de Educação, 1996, 27–119. ISBN 972-31-0713-9.
26.
go back to reference Pires C, Vigário M, Cavaco A. Package inserts of the most consumed medicines in Portugal: safety and regulatory compliance issues. A descriptive study. Sao Paulo Med J. 2015;133(2):91–100.CrossRefPubMed Pires C, Vigário M, Cavaco A. Package inserts of the most consumed medicines in Portugal: safety and regulatory compliance issues. A descriptive study. Sao Paulo Med J. 2015;133(2):91–100.CrossRefPubMed
29.
go back to reference Krejcie RV, Morgan DW. Determining sample size for research activities. Educ Psychol Meas. 1970;30:607–10. Krejcie RV, Morgan DW. Determining sample size for research activities. Educ Psychol Meas. 1970;30:607–10.
30.
go back to reference Pires C, Vigário M, Cavaco A. Brand names of Portuguese medication: understanding the importance of their linguistic structure and regulatory issues. Cien Saude Colet. 2015;20(8):2569–83.CrossRefPubMed Pires C, Vigário M, Cavaco A. Brand names of Portuguese medication: understanding the importance of their linguistic structure and regulatory issues. Cien Saude Colet. 2015;20(8):2569–83.CrossRefPubMed
34.
go back to reference Pires C, Cavaco A, Vigário M. Towards the definition of linguistic metrics for evaluating text readability in Portuguese (accepted by the J Quant Linguist in January 2016). Pires C, Cavaco A, Vigário M. Towards the definition of linguistic metrics for evaluating text readability in Portuguese (accepted by the J Quant Linguist in January 2016).
35.
go back to reference Collins SA, Currie LM, Bakken S, Vawdrey DK, Stone PW. Health literacy screening instruments for eHealth applications: a systematic review. J Biomed Inform. 2012;45(3):598–607.CrossRefPubMedPubMedCentral Collins SA, Currie LM, Bakken S, Vawdrey DK, Stone PW. Health literacy screening instruments for eHealth applications: a systematic review. J Biomed Inform. 2012;45(3):598–607.CrossRefPubMedPubMedCentral
Metadata
Title
Factors influencing subjects’ comprehension of a set of medicine package inserts
Authors
Carla Pires
Marina Vigário
Afonso Cavaco
Publication date
01-08-2016
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 4/2016
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-016-0305-6

Other articles of this Issue 4/2016

International Journal of Clinical Pharmacy 4/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.